NasdaqCM - Delayed Quote USD
Virpax Pharmaceuticals, Inc. (VRPX)
0.2500
+0.0100
+(4.17%)
At close: May 15 at 1:35:16 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-16,712.9000
-16,712.9000
-9,853.7720
-17,846.7080
-14,542.5920
Financing Cash Flow
9,084.4450
9,084.4450
0
0
51,329.7880
End Cash Position
1,513.0570
1,513.0570
9,141.5120
18,995.2840
36,841.9920
Income Tax Paid Supplemental Data
--
--
--
0
0
Interest Paid Supplemental Data
--
--
--
0
362.8220
Issuance of Capital Stock
6,317.2980
6,317.2980
0
0
58,020
Issuance of Debt
--
--
--
0
100
Repayment of Debt
--
--
--
0
-1,603.7640
Free Cash Flow
-16,712.9000
-16,712.9000
-9,853.7720
-17,846.7080
-14,542.5920
12/31/2021 - 2/17/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RNAZ TransCode Therapeutics, Inc.
7.65
-21.20%
SPRC SciSparc Ltd.
0.3059
-5.32%
OSRH OSR Holdings, Inc.
1.1400
-0.87%
SLXN Silexion Therapeutics Corp
0.9647
+2.20%
ZVSA ZyVersa Therapeutics, Inc.
0.5130
+1.12%
SXTP 60 Degrees Pharmaceuticals, Inc.
2.1500
-4.44%
DRMA Dermata Therapeutics, Inc.
0.7940
+1.93%
PALI Palisade Bio, Inc.
0.6801
-2.16%
ENSC Ensysce Biosciences, Inc.
2.1400
-7.36%
TVGN Tevogen Bio Holdings Inc.
1.1500
+4.55%